24/7 Wall Street
27 Jul 2026, 15:40 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
5 claims · each scored for market impact
The S&P 500 is rallying due to a pause in the U.S.-Iran war. — Geopolitical stabilization and the cessation of conflict typically trigger broad risk-on sentiment and a relief rally in equity markets.
+0.80Verizon has completed the Frontier acquisition, resulting in a 41.9% year-over-year increase in fiber broadband subscribers. — Significant growth in a key strategic segment and positive postpaid phone adds suggest a turnaround in operational growth for the carrier.
+0.40Johnson & Johnson's oncology portfolio is showing strong growth, with products Darzalex, Tremfya, and Carvykti growing between 22.5% and 68.3%. — Strong growth in high-margin specialty medicines offsets revenue erosion from biosimilars.
+0.30Continue reading
6 related stories
Top 1 mover · tap to explore
AbbVie's Skyrizi and Rinvoq are successfully replacing Humira revenue, with growth of 30.9% and 23.3% respectively in Q1 2026. — Successful transition to new blockbuster drugs reduces the risk of a long-term earnings cliff following Humira's patent expiration.
+0.30Realty Income has raised its 2026 AFFO guidance to a range of $4.41 to $4.44 per share. — Increased guidance for funds from operations indicates strong operational health and dividend sustainability for the REIT.
+0.20Which stocks this story touches
Strong dividend track record, raised 2026 AFFO guidance, and high portfolio occupancy.
Raised FY 2026 EPS guidance and successful replacement of Humira revenue with Skyrizi and Rinvoq.
Strong dividend yield, growing free cash flow, and positive subscriber growth following the Frontier acquisition.
Strong revenue growth in oncology and a prime AAA credit rating, though facing biosimilar erosion.
Mentioned as a historical success story for an analyst, providing a slight positive halo effect.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
24/7 Wall Street
1h ago
